Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.
A testosterone product lawsuit was filed by an Iowa man who alleges he suffered multiple heart attacks after taking AndroGel.
The testosterone side effects lawsuit filed by plaintiff Ronald Dewey cites several peer-reviewed medical studies that showed an increased risk of blood clot-related injuries in men taking various testosterone-based therapies, including AndroGel. According to these studies, men taking drugs like AndroGel experienced an increased risk of blood clots, causing a host of damaging medical problems including stroke, pulmonary embolism, deep vein thrombosis — and certain types of heart attack. Included were studies published in the prestigious Journal of the American Medical Association, or JAMA.
The testosterone gel lawsuit further alleges that not only are testosterone-replacement therapy dangerous, but that manufacturers are actively over-promoting them despite the risks. To support this allegation, the testosterone lawsuit cites another JAMA article that found as many as a quarter of men taking testosterone replacement drugs never had their testosterone levels directly tested, instead relying on vague symptoms like “fatigue” and “lack of energy,” to make the decision to start treatment with products like AndroGel. The study points to aggressive marketing both directly to patients and to health care providers.
The low-t drug lawsuits over AndroGel and other testosterone drugs have taken the form of a multidistrict litigation or MDL. MDLs are a type of group lawsuit, similar in some ways to class action lawsuits. In both class action lawsuits and MDLs, a group of plaintiffs allege that they have suffered similar harm at the hands of the same defendant. Group lawsuits like class action lawsuits and MDLs are designed to help streamline the legal process by converting tens, hundreds, or even thousands, of individual suits into a single coordinated legal action.
This AndroGel Lawsuit is titled Ronald Dewey, et al., v. AbbVie Inc., et al., Case No. 14-cv-1748, filed within the MDL In re: Testosterone Replacement Therapy Products Liability Litigation, MDL No. 2245, in the U.S. District Court for the Northern District of Illinois, Eastern Division.
In general, AndroGel heart attack lawsuits are filed individually by each plaintiff and are not class actions.
Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or class action lawsuit is best for you. Hurry — statutes of limitations may apply.
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2024 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.
Get Help – It’s Free
Join a Free Testosterone Product Class Action Lawsuit Investigation
If you or someone you know suffered a heart attack, stroke, blood clot, or other injury as a result of using a testosterone gel or cream, legal options are available. Find out if you qualify to join a free testosterone gel class action lawsuit investigation and pursue compensation for you or your loved one’s injuries by filling out the form below.
An attorney will contact you if you qualify to discuss the details of your potential case at no charge to you.
Oops! We could not locate your form.
